Tandem Diabetes Care
TNDM
$16.84
Share price
5.98%
Change (1 day)
-54.76%
Change (1 year)
Categories
Revenue for Tandem Diabetes Care (TNDM)
Revenue in 2025 (TTM): $0.98 Billion USD
According to Tandem Diabetes Care
's latest financial reports the company's current revenue (TTM 
) is $0.98 Billion USD. In 2024 the company made a revenue of $0.94 Billion USD an increase over the revenue in the year 2023 that were of $0.74 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Tandem Diabetes Care from 2013 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $0.98 B | 4.55% |
| 2024 | $0.94 B | 25.74% |
| 2023 | $0.74 B | -6.68% |
| 2022 | $0.80 B | 14% |
| 2021 | $0.70 B | 40.89% |
| 2020 | $0.49 B | 37.68% |
| 2019 | $0.36 B | 97.05% |
| 2018 | $0.18 B | 70.88% |
| 2017 | $0.10 B | 27.72% |
| 2016 | $84.24 M | 15.65% |
| 2015 | $72.85 M | 46.51% |
| 2014 | $49.72 M | 71.42% |
| 2013 | $29 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Insulet PODD | $2.19 B | 123.70% | 🇺🇸 USA |
 ICU Medical
ICUI | $2.42 B | 146.21% | 🇺🇸 USA |
 DexCom DXCM | $4.14 B | 321.99% | 🇺🇸 USA |
 Medtronic MDT | $33.53 B | 3,311.87% | 🇮🇪 Ireland |
 Johnson & Johnson JNJ | $89.33 B | 8,988.04% | 🇺🇸 USA |